Second-Line Therapy in EGFR Activating Mutation Positive Advanced NSCLC: Analysis from a Randomized Phase III First-Line Trial

Ramaswamy, A; Patil, V; Joshi, A; Noronha, V; Chougule, A; Mahajan, A; Goud, S; More, S; Karpe, A; Pande, N; Chandrasekharan, A; Goel, A; Talreja, V; Prabhash, K

JOURNAL OF THORACIC ONCOLOGY, 2017; 12 (1): S1225

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索